Athersys Inc (ATHXQ)

Currency in USD
0.000001
0.000000(0.00%)
Delayed Data·

Athersys Inc Company Profile

Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area. Its stem cell product candidate is the MultiStem cell therapy, an allogeneic stem cell product for the treatment of indications in the neurological, inflammatory and immune, and cardiovascular disease areas, as well as other critical care conditions. The company was founded in 1995 and is headquartered in Cleveland, Ohio. On September 24, 2024, the voluntary petition of Athersys, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy along with its affiliates on January 5, 2024.

Contact Information

Address
3201 Carnegie Avenue, Cleveland, 44115-2634, United States
Phone
216 431 9900
Fax
216 361 9495

Top Executives

Name
Title
Since
Age
Z. Kasey RosadoInterim CFO & Director202452
James G. ShookScientific and Clinical Advisor200086
C. Thomas CaskeyScientific and Clinical Advisor200086
Catherine VerfaillieScientific and Clinical Advisor--
Michael SimonsScientific and Clinical Advisor--
Ira MellmanScientific and Clinical Advisor--
Gilbert ClinckeScientific and Clinical Advisor--
Brian H. AnnexScientific and Clinical Advisor--
F. Xavier Pi-SunyerScientific and Clinical Advisor--
John WagnerScientific & Clinical Advisor--
Jerry SilverScientific and Clinical Advisor--
Larry WechslerScientific and Clinical Advisor--
Warren ShermanScientific and Clinical Advisor-75
Marc Steven PennScientific and Clinical Advisor--
Richard T. MaziarzScientific & Clinical Advisor--
Hillard M. LazarusScientific & Clinical Advisor--
Robert F. KushnerScientific and Clinical Advisor--
David HessScientific and Clinical Advisor--
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.